Journals / European Journal of Breast Health / 2019 / Cilt: 15 - Sayı: 1

Complications Associated with Loco-Regional Treatment of Breast Cancer and Their Impact on Quality-of-Life

Pages
51–58
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Social area scores were significantlyincreased, whereas environmental, mental and physical area scores were significantly decreased in mid-term and late period.Conclusion: Overall, patients’ quality-of-life was found to be significantly deteriorated in both early period and mid-term and returned to pretreatmentperiod at long term follow up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Aim of this prospective study was to determine the complications of different treatment modalities for breast cancer and assess theirimpact on patients’ quality-of-life and psychological status.Materials and Methods: Patients surgically treated for early-stage breast cancer were enrolled in the study.
📊
Key Findings & Data:Complications after treatment andquality-of-life parameters were measured and recorded.Results: 218 patients, all female with a median age of 48 (19-82) years, were included in the study.
💡
Conclusion & Impact:Social area scores were significantlyincreased, whereas environmental, mental and physical area scores were significantly decreased in mid-term and late period.Conclusion: Overall, patients’ quality-of-life was found to be significantly deteriorated in both early period and mid-term and returned to pretreatmentperiod at long term follow up.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Aim of this prospective study was to determine the complications of different treatment modalities for breast cancer and assess theirimpact on patients’ quality-of-life and psychological status.Materials and Methods: Patients surgically treated for early-stage breast cancer were enrolled in the study. Complications after treatment andquality-of-life parameters were measured and recorded.Results: 218 patients, all female with a median age of 48 (19-82) years, were included in the study. In early period, significant limitation of shouldermovements, increased pain and decreased in functional capacity were observed, whereas in mid-term, all shoulder movements, as well as painand functional capacity returned normal. In both early period and mid-terms, anxiety scores were significantly decreased, whereas depression scoreswere significantly increased. In early period, there was a significant decrease in physical and mental area scores. Social area scores were significantlyincreased, whereas environmental, mental and physical area scores were significantly decreased in mid-term and late period.Conclusion: Overall, patients’ quality-of-life was found to be significantly deteriorated in both early period and mid-term and returned to pretreatmentperiod at long term follow up.

🔖

Cite This Article

GÜLER, S. A., GÜLLÜOĞLU, B. M., KOCAMAN, N., ÖZKAN, M., Özmen, V., ÖZÇINAR, B. (2022). Complications Associated with Loco-Regional Treatment of Breast Cancer and Their Impact on Quality-of-Life. European Journal of Breast Health, Cilt: 15 - Sayı: 1, 51–58. https://ajindex.com/articles/510801

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Jemal A, Siegel R, Wand E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics 2006. CA Cancer J Clin 2006
  2. (PMID: 16514137) [CrossRef] 2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005
  3. (PMID: 15761078) [CrossRef] 3. Velloso FS, Barra AA, Dias RC. Functional performance of upper limb and quality of life after sentinel lymph node biopsy of breast cancer. Rev Bras Fisioter 2011
  4. (PMID: 21789365) [CrossRef] 4. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002
  5. (PMID: 12393820) [CrossRef] 5. Krag DN, Julian TB, Harlow SP, Weaver DL, Ashikaga T, Bryant J, Single RM, Wolmark N. NSABP-32: Phase III, Randomized Trial Comparing Axillary Resection with Sentinel Lymph Node Dissection. Ann Surg Oncol 2004
  6. (PMID: 15023753) [CrossRef] 6. Vanderveen KA, Schneider PD, Khatri VP, Goodnight JE, Bold RJ. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Ann Surg Oncol 2006
  7. (PMID: 17009150) [CrossRef] 7. Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, Klimberg VS, Kusminsky R, Moffat FL Jr, Noyes RD, Beitsch PD. Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically nodenegative breast cancer. Ann Surg 2005
  8. (PMID: 15621990) 8. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, Mazzarol G, De Cicco C, Manfredi G, Fernández JR. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006
  9. (PMID: 17138219) [CrossRef] 9. Veronesi U, Galimberti V, Mariani L, Gatti G, Paganelli G, Viale G, Zurrida S, Veronesi P, Intra M, Gennari R, Rita Vento A, Luini A, Tullii M, Bassani G, Rotmensz N. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 2005
  10. (PMID: 15661547) [CrossRef] 10. Legin BG, Iannotti JP: Shoulde